Your browser doesn't support javascript.
loading
Risk Factors for a Higher Symptom Burden in Patients With Cancer During the COVID-19 Pandemic.
Hun Kwak, Ji; Mackin, Lynda A; Block, Astrid; Paul, Steven M; Cooper, Bruce A; Abbott, Maura; Chang, Susan M; Hammer, Marilyn J; Kober, Kord M; Levine, Jon D; Pozzar, Rachel; Rhoads, Kim F; Snowberg, Karin E; Tsai, Katy K; Van Blarigan, Erin L; Van Loon, Katherine; Miaskowski, Christine.
Afiliação
  • Hun Kwak J; University of California, San Francisco.
  • Mackin LA; University of California, San Francisco.
  • Block A; University of California, San Francisco.
  • Paul SM; University of California, San Francisco.
  • Cooper BA; University of California, San Francisco.
  • Abbott M; Columbia University.
  • Chang SM; University of California, San Francisco.
  • Hammer MJ; Dana-Farber Cancer Institute.
  • Kober KM; University of California, San Francisco.
  • Levine JD; University of California, San Francisco.
  • Pozzar R; Dana-Farber Cancer Institute.
  • Rhoads KF; University of California, San Francisco.
  • Snowberg KE; University of California, San Francisco.
  • Tsai KK; University of California, San Francisco.
  • Van Blarigan EL; University of California, San Francisco.
  • Van Loon K; University of California, San Francisco.
  • Miaskowski C; University of California, San Francisco.
Oncol Nurs Forum ; 50(5): 647-664, 2023 08 17.
Article em En | MEDLINE | ID: mdl-37677766
ABSTRACT

OBJECTIVES:

To evaluate for subgroups of patients with distinct symptom profiles and differences in demographic and clinical characteristics and stress and resilience among these subgroups. SAMPLE &

SETTING:

1,145 patients with cancer aged 18 years or older completed a survey online. Data were collected between May 2020 and February 2021. METHODS & VARIABLES Patients completed measures for depression, state anxiety, cognitive function, morning fatigue, evening fatigue, morning energy, evening energy, sleep disturbance, pain, stress, and resilience. Latent class profile analysis was used to identify subgroups of patients with distinct symptom profiles. Differences among the subgroups on study measures were evaluated using parametric and nonparametric tests.

RESULTS:

Four distinct profiles were identified (none, low, high, and very high). Patients in the high and very high classes reported clinically meaningful levels of all nine symptoms. Differences among the four profiles for stress and resilience exhibited a dose-response effect. IMPLICATIONS FOR NURSING Findings can serve as benchmark data of the symptom burden of patients with cancer following the COVID-19 pandemic.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncol Nurs Forum Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncol Nurs Forum Ano de publicação: 2023 Tipo de documento: Article